Impact of Alpha-Radiotherapy on the Tumor Microenvironment

M Allard, J Perrin, Y Guilloux, F Kraeber-Bodéré… - Handbook of Cancer …, 2022 - Springer
Alpha-radiotherapy is an internal radiation therapy based on the use of α-particle emitters.
These radionuclides are highly cytotoxic and altogether their characteristics make them of …

Targeted and nontargeted α-particle therapies

MR McDevitt, G Sgouros, S Sofou - Annual review of biomedical …, 2018 - annualreviews.org
α-Particle irradiation of cancerous tissue is increasingly recognized as a potent therapeutic
option. We briefly review the physics, radiobiology, and dosimetry of α-particle emitters, as …

[图书][B] Alpha-radioimmunotherapy with At-211: Evaluations and imaging on normal tissues and tumors

T Bäck - 2011 - gupea.ub.gu.se
Alpha-radioimmunotherapy (alpha-RIT) is an internal conformal radiotherapy at the cellular
level using alpha-particle emitting radionuclides. Alpha-particles have a very short range in …

α-particle–emitter radiopharmaceutical therapy: resistance is futile

G Sgouros - Cancer Research, 2019 - AACR
Alpha-emitter radiopharmaceutical therapy (α-RPT) is a treatment modality that is
impervious to conventional cellular resistance mechanisms because of the unique …

428 Diffusing alpha-emitters radiation therapy promotes a pro-immunogenic tumor microenvironment and synergizes with PD-1 blockade

S Roumani, Y Nishri, A Shai, M Efrati, I Kelson… - 2022 - jitc.bmj.com
Background Diffusing alpha emitters radiation therapy (DaRT) utilizes Ra-224 loaded seeds
that continuously release alpha-emitting atoms inside the tumor. 1 The treatment effectively …

Effects of alpha particles on cells

D Valiukevičiūtė - 2024 - epubl.ktu.edu
Abstract [eng] Targeted alpha therapy (TAT) shows promising results for precise and
selective radiotherapy with effective cancer treatment and minimal toxicity. Alpha particle …

Revisiting the radiobiology of targeted alpha therapy

JP Pouget, J Constanzo - Frontiers in Medicine, 2021 - frontiersin.org
Targeted alpha therapy (TAT) using alpha particle-emitting radionuclides is in the spotlight
after the approval of 223RaCl2 for patients with metastatic castration-resistant prostate …

Targeted α-particle therapy: a clinical overview

M Salvatori, L Indovina, L Mansi - Current …, 2008 - ingentaconnect.com
Among radionuclides usable for tumor therapy, α-particle emitters are characterized by a
very high linear energy transfer (LET) resulting in a larger number of ionizations in a range …

Targeted alpha-particle therapy: a review of current trials

A Jang, AT Kendi, GB Johnson… - International journal of …, 2023 - mdpi.com
Radiopharmaceuticals are rapidly developing as a field, with the successful use of targeted
beta emitters in neuroendocrine tumors and prostate cancer serving as catalysts. Targeted …

[PDF][PDF] Modelling the Effectiveness of Alpha Particle Radionuclides in Clinical Settings

MAS Pereira - 2021 - researchgate.net
A utilização de radionuclídeos que emitem partículas alfa ocorre desde a sua aprovação
clínica em 2013, com diferentes graus de sucesso. Apesar da sua utilidade clínica, pouco se …